Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (TSHA) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 90 transactions totaling $29.6M, demonstrating a bullish sentiment with $14.3M in net insider flow. The most recent transaction on Jan 26, 2026 involved a sale of 23,849 shares valued at $109.9K.
TSHA Insider Activity Summary
Who Is Buying TSHA Stock?
No significant insider buying has been recorded for TSHA in the recent period.
Who Is Selling TSHA Stock?
No significant insider selling has been recorded for TSHA in the recent period.
Is Taysha Gene Therapies, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TSHA is bullish with an Insider Alignment Score of 74/100 and a net flow of $14.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TSHA Frequently Asked Questions
Understanding TSHA Insider Activity
Insider trading at Taysha Gene Therapies, Inc. (TSHA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading TSHA stock, having executed 90 transactions in the past 90 days. The most active insider is Paul B. Manning (Executive), who has made 15 transactions totaling $20.1M.
Related Tools
Track Taysha Gene Therapies, Inc. Insider Activity
Get notified when executives and directors at TSHA file new Form 4 transactions